# A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study

> **NCT04269395** · PHASE3 · TERMINATED · sponsor: **Galderma R&D** · enrollment: 125 (actual)

## Conditions studied

- Keratosis, Actinic

## Interventions

- **DRUG:** MAL Cream
- **DRUG:** Vehicle cream

## Key facts

- **NCT ID:** NCT04269395
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-04-07
- **Primary completion:** 2021-09-01
- **Final completion:** 2021-09-01
- **Target enrollment:** 125 (ACTUAL)
- **Why stopped:** The study was terminated early as per Sponsor's decision
- **Last updated:** 2023-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04269395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04269395, "A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04269395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*